Dr. Christopher Wade Babl, MD

Dr. Babl practices at Tallahassee Outpatient Surgery Center in Tallahassee, Florida.

Dr. Babl's NPI, 1073660841, was assigned on January 4, 2007. Dr. Babl graduated from UNMC in 2013. Dr. Babl holds Florida license ME131621.

Dr. Babl's primary practice is Tallahassee Outpatient Surgery Center, at 3334 Capital Medical Blvd, Ste 500, Tallahassee, FL 32308. The practice phone is (904) 877-4688.

Dr. Babl's primary practice is Tallahassee Outpatient Surgery Center in Tallahassee, Florida. Dr. Babl is also affiliated with HCA Florida Capital Hospital. The medical group on file is Tallahassee Orthopedic Clinic. Dmand AI also links Dr. Babl to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babl practices, 4 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Babl's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Babl is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Babl's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Babl treats.

CMS data shows 22,851 Medicare services from Dr. Babl across 23 procedure codes in 2024, for 315 Medicare patients. Medicare paid $124,699 for them. Every service was in an office.

CMS counts 315 Medicare patients who saw Dr. Babl in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Babl's median patient age at 69, with 59% women.

In 2024, Dr. Babl wrote 2,984 Medicare Part D claims for 585 patients. 99% of them were for generic drugs. CMS names the drug for 2,916 of them, across 24 drugs with 11 or more claims each, at $59,591 in total drug cost. In 2023, CMS named 2,913 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Babl for performance year 2024, reported as part of a group. Dr. Babl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Babl in 2019. Dr. Babl's most frequent co-authors are Alan D. Kaye, MD, Michael Patrick Kinsky, MD and Rene Przkora, MD, MMSC, PhD.

CMS Open Payments shows 64 general payments to Dr. Babl from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 45% of the total. Medtronic USA, Inc. paid the most, $4,019.

Dr. Babl graduated from UNMC in 2013.

Dr. Babl is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.